• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors.

作者信息

Kraljić I, Tarle M

机构信息

Clinic of Urology, Clinical Hospital Dr M. Stojanović, Zagreb, Croatia, Yugoslavia.

出版信息

Prog Clin Biol Res. 1987;243B:521-5.

PMID:3659050
Abstract
摘要

相似文献

1
Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors.通过评估肿瘤标志物和激素参数对前列腺癌内分泌治疗进行评估。对假性内分泌非依赖性肿瘤进行激素“交叉”治疗。
Prog Clin Biol Res. 1987;243B:521-5.
2
Endocrine therapy in the management of advanced prostatic cancer: the case for early initiation of treatment.
Urol Clin North Am. 1980 Oct;7(3):639-43.
3
[Current value of hormonotherapy in cancer of the prostate].[激素疗法在前列腺癌治疗中的当前价值]
Minerva Urol Nefrol. 1984 Oct-Dec;36(4):329-35.
4
Monitoring of prostate volume by ultrasound in hormonally treated prostate cancer.激素治疗的前列腺癌患者前列腺体积的超声监测
Prog Clin Biol Res. 1987;243B:13-9.
5
The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.转移性前列腺癌早期联合激素与细胞抑制治疗的病例分析
Prog Clin Biol Res. 1987;243B:449-53.
6
The questionable use of hormone therapy in advanced carcinoma of the prostate.激素疗法在晚期前列腺癌中的可疑应用。
Urol Clin North Am. 1980 Oct;7(3):631-8.
7
Deferred hormone treatment in prostate cancer.前列腺癌的延迟激素治疗
Prog Clin Biol Res. 1987;243B:439-40.
8
Using surrogate biomarkers to predict clinical benefit in men with castration-resistant prostate cancer: an update and review of the literature.使用替代生物标志物预测去势抵抗性前列腺癌男性患者的临床获益：文献更新与综述
Oncologist. 2009 Aug;14(8):816-27. doi: 10.1634/theoncologist.2009-0043. Epub 2009 Aug 14.
9
[Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer].[前列腺特异性抗原的动态变化作为前列腺癌内分泌治疗的预后因素]
Hinyokika Kiyo. 1999 Jan;45(1):31-5.
10
Hormonally responsive versus unresponsive progression of prostatic cancer to antiandrogen therapy as studied with the Dunning R-3327-AT and -G rat adenocarcinomas.
Cancer Res. 1982 Dec;42(12):5010-4.